Thimble Point

$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can watch Thimble Point and buy or sell other stocks, options, and ETFs commission-free!

About THMA

Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA.

CEO
Corey M. McCann, MD, PhD
Employees
300
Headquarters
Boston, Massachusetts
Founded
2020

THMA Key Statistics

Market cap
1.28B
Price-Earnings ratio
—
Dividend yield
—
Average volume
359.86K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$14.60
52 Week low
$2.81
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure